Works matching AU Tajiri, Kazuto

Results: 96

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Published in:

Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192

By:

Hatanaka, Takeshi;
Yata, Yutaka;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Kakizaki, Satoru;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Koshiyama, Yuichi;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi

Publication type:

Article

Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2024, v. 102, n. 2, p. 131, doi. 10.1159/000533952

By:

Tajiri, Kazuto;
Tsukada, Kenichiro;
Tokimitsu, Yoshiharu;
Motofuji, Yuchi;
Kawai, Kengo;
Muraishi, Nozomu;
Murayama, Aiko;
Hayashi, Yuka;
Shimizu, Yukihiro;
Yasuda, Ichiro

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Published in:

Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Published in:

Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

Published in:

Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Fukunishi, Shinya;
Ohama, Hideko;
Kawata, Kazuhito

Publication type:

Article

Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko;
Tsutsui, Akemi;
Itokawa, Norio

Publication type:

Article

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.

Published in:

Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74

By:

Nouso, Kazuhiro;
Shiota, Shohei;
Fujita, Rio;
Wakuta, Akiko;
Kariyama, Kazuya;
Hiraoka, Atsushi;
Atsukawa, Masanori;
Tani, Joji;
Tada, Toshifumi;
Matsuo, Yu;
Nakamura, Shinichiro;
Tajiri, Kazuto;
Kaibori, Masaki;
Hirooka, Masashi;
Itobayashi, Ei;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Hatanaka, Takeshi;
Fukunishi, Shinya

Publication type:

Article

Comparison of Histological Sample Volumes among Various Endoscopic Ultrasound-Guided Biopsy Needles.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3560, doi. 10.3390/jcm10163560

By:

Takahashi, Kosuke;
Yasuda, Ichiro;
Hanaoka, Tatsuyuki;
Hayashi, Yuka;
Motoo, Iori;
Kajiura, Shinya;
Ando, Takayuki;
Fujinami, Haruka;
Tajiri, Kazuto;
Imura, Johji;
Ozawa, Eisuke;
Miuma, Satoshi;
Miyaaki, Hisamitsu;
Nakao, Kazuhiko

Publication type:

Article

Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355

By:

Atsushi Hiraoka;
Takashi Kumada;
Toshifumi Tada;
Kazuya Kariyama;
Joji Tani;
Shinya Fukunishi;
Masanori Atsukawa;
Masashi Hirooka;
Kunihiko Tsuji;
Toru Ishikawa;
Koichi Takaguchi;
Ei Itobayashi;
Kazuto Tajiri;
Noritomo Shimada;
Hiroshi Shibata;
Hironori Ochi;
Kazuhito Kawata;
Satoshi Yasuda;
Hidenori Toyoda;
Hideko Ohama

Publication type:

Article

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Yokohama, Keisuke;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya

Publication type:

Article

Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Kawata, Kazuhito

Publication type:

Article

A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan.

Published in:

2024

By:

Yamaguchi, Satoshi;
Yamazaki, Miho;
Kido, Toshiki;
Hounoki, Hiroyuki;
Muraishi, Nozomu;
Tajiri, Kazuto;
Tanaka, Shinichi;
Tobe, Kazuyuki;
Shinoda, Koichiro

Publication type:

Case Study

Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection.

Published in:

Viruses (1999-4915), 2025, v. 17, n. 1, p. 44, doi. 10.3390/v17010044

By:

Tajiri, Kazuto;
Hayashi, Yuka;
Murayama, Aiko;
Muraishi, Nozomu;
Minemura, Masami;
Yasuda, Ichiro

Publication type:

Article

Peritumoral Hyperplasia in Hepatic Sclerosed Hemangioma.

Published in:

ACG Case Reports Journal, 2017, v. 4, p. 1, doi. 10.14309/crj.2017.61.PublishedonlineApril26,2017

By:

Seitarou Shimada;
Kazuto Tajiri;
Hayato Baba;
Masami Minemura;
Koichi Tsuneyama;
Masayuki Nakano;
Toshiro Sugiyama

Publication type:

Article

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Takaguchi, Koichi;
Atsukawa, Masanori;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Hirooka, Masashi;
Shimada, Noritomo;
Shibata, Hiroshi;
Ishikawa, Toru;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Itokawa, Norio;
Imai, Michitaka;
Joko, Kouji

Publication type:

Article

Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

CD8 Positive T Lymphocyte Infiltration of Liver Metastases of Uveal Melanoma: A Case Report.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.672660

By:

Takahashi, Naoki;
Tajiri, Kazuto;
Kagoyana, Ko;
Tanaka, Shinichi;
Yasuda, Ichiro

Publication type:

Article

A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma.

Published in:

2024

By:

Kawanaka, Hiroki;
Tajiri, Kazuto;
Muraishi, Nozomu;
Murayama, Aiko;
Nukui, Takamasa;
Yasuda, Ichiro

Publication type:

Case Study

Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia.

Published in:

Case Reports in Gastroenterology, 2021, v. 15, n. 2, p. 729, doi. 10.1159/000518306

By:

Murayama, Aiko;
Tajiri, Kazuto;
Kanegane, Chiharu;
Murakami, Jun;
Hayashi, Yuka;
Yasuda, Ichiro

Publication type:

Article

Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment.

Published in:

Case Reports in Gastroenterology, 2021, v. 15, n. 2, p. 645, doi. 10.1159/000516199

By:

Murayama, Aiko;
Tajiri, Kazuto;
Nakaya, Atsuko;
Ito, Hiroyuki;
Hayashi, Yuka;
Entani, Toshiki;
Nagata, Kohei;
Tanaka, Shinichi;
Hamashima, Takeru;
Yasuda, Ichiro

Publication type:

Article

Perforation of the Small Intestine after Introduction of Lenvatinib in a Patient with Advanced Hepatocellular Carcinoma.

Published in:

Case Reports in Gastroenterology, 2020, v. 14, n. 1, p. 63, doi. 10.1159/000505774

By:

Suzuki, Naomi;
Tajiri, Kazuto;
Futsukaichi, Yuka;
Tanaka, Shinichi;
Murayama, Aiko;
Entani, Toshiki;
Kobayashi, Saito;
Takahashi, Kosuke;
Fujii, Tsutomu;
Imura, Johji;
Yasuda, Ichiro

Publication type:

Article

Vanishing Tumor in a Liver Graft from a Hepatitis B Virus Surface Antigen-Positive Donor.

Published in:

Case Reports in Gastroenterology, 2017, v. 11, n. 3, p. 610, doi. 10.1159/000481164

By:

Fuchino, Mayo;
Tajiri, Kazuto;
Minemura, Masami;
Sugiyama, Toshiro

Publication type:

Article

Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir.

Published in:

Case Reports in Gastroenterology, 2016, v. 10, n. 2, p. 352, doi. 10.1159/000447486

By:

Baba, Hayato;
Tajiri, Kazuto;
Nagata, Kohei;
Kawai, Kengo;
Minemura, Masami;
Sugiyama, Toshiro

Publication type:

Article

A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab.

Published in:

Case Reports in Gastroenterology, 2013, v. 7, n. 1, p. 195, doi. 10.1159/000351173

By:

Tajiri, Kazuto;
Tsuneyama, Koichi;
Miyazono, Takahiro;
Kawai, Kengo;
Minemura, Masami;
Sugiyama, Toshiro

Publication type:

Article

Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.

Published in:

Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 5, p. 465, doi. 10.1111/1744-9987.12563

By:

Toyoda, Hidenori;
Hiraoka, Atsushi;
Tada, Toshifumi;
Michitaka, Kojiro;
Takaguchi, Koichi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Takizawa, Daichi;
Hirooka, Masashi;
Koizumi, Yohei;
Ochi, Hironori;
Joko, Koji;
Kisaka, Yoshiyasu;
Shimizu, Yuko;
Tajiri, Kazuto;
Tani, Joji;
Taniguchi, Tatsuya;
Toshimori, Akiko;
Fujioka, Shinichi;
Kumada, Takashi

Publication type:

Article

Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals.

Published in:

BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02829-w

By:

Tajiri, Kazuto;
Okada, Kazuhiko;
Ito, Hiroyuki;
Kawai, Kengo;
Kashii, Yoshiro;
Tokimitsu, Yoshiharu;
Muraishi, Nozomu;
Murayama, Aiko;
Hayashi, Yuka;
Minemura, Masami;
Takahara, Terumi;
Shimizu, Yukihiro;
Yasuda, Ichiro

Publication type:

Article

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

Published in:

Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Ogawa, Chikara;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 949, doi. 10.1111/jgh.16884

By:

Matono, Tomomitsu;
Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tanaka, Kazunari;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi

Publication type:

Article

Reliable Performance of mALBI Grade‐Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First‐Line Treatment: Comparative Analysis of 13 Risk Models.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 930, doi. 10.1111/jgh.16871

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

Published in:

Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1389, doi. 10.1111/jgh.16225

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.

Published in:

Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Tada, Toshifumi;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 6, p. 1066, doi. 10.1111/jgh.14564

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Deguchi, Akihiro;
Ishikawa, Toru;
Imai, Michitaka;
Ochi, Hironori;
Joko, Koji;
Shimada, Noritomo;
Tajiri, Kazuto;
Hirooka, Masashi;
Koizumi, Yohei;
Hiasa, Yoichi;
Tanaka, Junko

Publication type:

Article

Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection.

Published in:

Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 7, p. 1291, doi. 10.1111/jgh.13287

By:

Tajiri, Kazuto;
Baba, Hayato;
Kawai, Kengo;
Minemura, Masami;
Yasumura, Satoshi;
Takahara, Terumi;
Sugiyama, Toshiro

Publication type:

Article

Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis.

Published in:

Digestive Diseases, 2018, v. 36, n. 4, p. 314, doi. 10.1159/000489258

By:

Tajiri, Kazuto;
Tokimitsu, Yoshiharu;
Ito, Hiroyuki;
Atarashi, Yoshinari;
Kawai, Kengo;
Minemura, Masami;
Yasumura, Satoshi;
Takahara, Terumi;
Shimizu, Yukihiro;
Sugiyama, Toshiro

Publication type:

Article

Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256

By:

Atsushi Hiraoka;
Takashi Kumada;
Masatoshi Kudo;
Masashi Hirooka;
Yohei Koizumi;
Yoichi Hiasa;
Kazuto Tajiri;
Hidenori Toyoda;
Toshifumi Tada;
Hironori Ochi;
Koji Joko;
Noritomo Shimada;
Akihiro Deguchi;
Toru Ishikawa;
Michitaka Imai;
Kunihiko Tsuji;
Kojiro Michitaka

Publication type:

Article

Role of NKT Cells in the Pathogenesis of NAFLD.

Published in:

International Journal of Hepatology, 2012, p. 1, doi. 10.1155/2012/850836

By:

Tajiri, Kazuto;
Shimizu, Yukihiro

Publication type:

Article

Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection.

Published in:

Medicina (1010660X), 2024, v. 60, n. 8, p. 1334, doi. 10.3390/medicina60081334

By:

Hayashi, Yuka;
Tajiri, Kazuto;
Ozawa, Tatsuhiko;
Angata, Kiyohiko;
Sato, Takashi;
Togayachi, Akira;
Nagashima, Izuru;
Shimizu, Hiroki;
Murayama, Aiko;
Muraishi, Nozomu;
Narimatsu, Hisashi;
Yasuda, Ichiro

Publication type:

Article

Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma.

Published in:

Cancer Medicine, 2025, v. 14, n. 2, p. 1, doi. 10.1002/cam4.70618

By:

Naganuma, Atsushi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hatanaka, Takeshi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.

Published in:

Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Yokohama, Keisuke;
Nishikawa, Hiroki

Publication type:

Article

Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.

Published in:

Cancer Medicine, 2023, v. 12, n. 17, p. 17849, doi. 10.1002/cam4.6416

By:

Nouso, Kazuhiro;
Shiota, Shohei;
Fujita, Rio;
Wakuta, Akiko;
Kariyama, Kazuya;
Hiraoka, Atsushi;
Atsukawa, Masanori;
Tani, Joji;
Tada, Toshifumi;
Nakamura, Shinichiro;
Tajiri, Kazuto;
Kaibori, Masaki;
Hirooka, Masashi;
Itobayashi, Ei;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Hatanaka, Takeshi;
Fukunishi, Shinya;
Tsuji, Kunihiko

Publication type:

Article

Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Published in:

Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.

Published in:

Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.

Published in:

Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Shimada, Noritomo

Publication type:

Article